CN Patent

CN115397406A — 施用γ-羟基丁酸组合物与双丙戊酸钠的方法

Assigned to Flamel Ireland Ltd · Expires 2022-11-25 · 3y expired

What this patent protects

本发明提供了γ‑羟基丁酸(GHB)的口服药物组合物，其适于与一定剂量的双丙戊酸钠(DVP)同时施用，而不会实质上改变任一药品的剂量。还提供了所述组合物用于治疗发作性睡病的一种或多种症状的治疗用途。

USPTO Abstract

本发明提供了γ‑羟基丁酸(GHB)的口服药物组合物，其适于与一定剂量的双丙戊酸钠(DVP)同时施用，而不会实质上改变任一药品的剂量。还提供了所述组合物用于治疗发作性睡病的一种或多种症状的治疗用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN115397406A
Jurisdiction
CN
Classification
—
Expires
2022-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Flamel Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.